Kodiak Sciences Inc. (KOD) stock
KODNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$96.80−3.93 (-3.90%)
Close on Nov 17, 2026Market cap $6.08BP/E –Yield –
Kodiak Sciences total assets
Total assets on the balance sheet at the end of each period.
Kodiak Sciences's total assets was $256.81M at Jun 30, 2026. For fiscal 2025 it was $351.53M, up 4.8% from the year before. The highest annual figure on record is $1.07B in fiscal 2020.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $351.53M | +4.8% |
| FY2024 | Dec 31, 2024 | $335.58M | -30.0% |
| FY2023 | Dec 31, 2023 | $479.37M | -28.1% |
| FY2022 | Dec 31, 2022 | $666.63M | -26.3% |
| FY2021 | Dec 31, 2021 | $904.22M | -15.3% |
| FY2020 | Dec 31, 2020 | $1.07B | +197.4% |
| FY2019 | Dec 31, 2019 | $358.87M | +289.3% |
| FY2018 | Dec 31, 2018 | $92.19M | +2741.8% |
| FY2017 | Dec 31, 2017 | $3.24M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $256.81M | +0.0% |
| Q1 FY2026 | Mar 31, 2026 | $306.01M | +2.7% |
| Q4 FY2025 | Dec 31, 2025 | $351.53M | +4.8% |
| Q3 FY2025 | Sep 30, 2025 | $218.07M | -41.5% |
| Q2 FY2025 | Jun 30, 2025 | $256.73M | -36.1% |
| Q1 FY2025 | Mar 31, 2025 | $297.91M | -31.5% |
| Q4 FY2024 | Dec 31, 2024 | $335.58M | -30.0% |
| Q3 FY2024 | Sep 30, 2024 | $372.67M | -32.0% |
| Q2 FY2024 | Jun 30, 2024 | $401.58M | -31.9% |
| Q1 FY2024 | Mar 31, 2024 | $434.76M | -32.1% |
| Q4 FY2023 | Dec 31, 2023 | $479.37M | -28.1% |
| Q3 FY2023 | Sep 30, 2023 | $547.65M | -24.4% |
| Q2 FY2023 | Jun 30, 2023 | $589.66M | -24.6% |
| Q1 FY2023 | Mar 31, 2023 | $640.33M | -24.7% |
| Q4 FY2022 | Dec 31, 2022 | $666.63M | -26.3% |
| Q3 FY2022 | Sep 30, 2022 | $723.99M | -24.4% |
| Q2 FY2022 | Jun 30, 2022 | $781.91M | -21.6% |
| Q1 FY2022 | Mar 31, 2022 | $850.29M | -17.7% |
| Q4 FY2021 | Dec 31, 2021 | $904.22M | -15.3% |
| Q3 FY2021 | Sep 30, 2021 | $958.21M | +99.3% |
| Q2 FY2021 | Jun 30, 2021 | $997.60M | +132.3% |
| Q1 FY2021 | Mar 31, 2021 | $1.03B | +133.1% |
| Q4 FY2020 | Dec 31, 2020 | $1.07B | +197.4% |
| Q3 FY2020 | Sep 30, 2020 | $480.74M | +597.6% |
| Q2 FY2020 | Jun 30, 2020 | $429.37M | +448.5% |
| Q1 FY2020 | Mar 31, 2020 | $443.04M | +408.8% |
| Q4 FY2019 | Dec 31, 2019 | $358.87M | +289.3% |
| Q3 FY2019 | Sep 30, 2019 | $68.92M | +302.7% |
| Q2 FY2019 | Jun 30, 2019 | $78.28M | +2312.9% |
| Q1 FY2019 | Mar 31, 2019 | $87.08M | – |
| Q4 FY2018 | Dec 31, 2018 | $92.19M | – |
| Q3 FY2018 | Sep 30, 2018 | $17.12M | – |
| Q4 FY2017 | Dec 31, 2017 | $3.24M | – |
See a number that looks wrong?